NewslettersCell Therapy NewsUncategorizedCombine and Conquer: Manganese Synergizing Anti-TGF-β/PD-L1 Bispecific Antibody YM101 to Overcome Immunotherapy Resistance in Non-Inflamed CancersBy Justin.choi - September 20, 2021090The synergistic effect between Bivalent manganese and YM101 in vitro was determined by one-way mixed lymphocyte reaction, CFSE dilution assay, and cytokine detection.[Journal of Hematology & Oncology] 6445212 AAAAAAAA items 1 apa 0 default asc 1 166933 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article